Penserra Capital Management LLC Purchases Shares of 129,396 Alignment Healthcare, Inc. (NASDAQ:ALHC)

Penserra Capital Management LLC bought a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 129,396 shares of the company's stock, valued at approximately $2,409,000. Penserra Capital Management LLC owned about 0.07% of Alignment Healthcare as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently modified their holdings of the stock. Proficio Capital Partners LLC purchased a new stake in shares of Alignment Healthcare during the fourth quarter valued at approximately $184,000. US Bancorp DE grew its holdings in Alignment Healthcare by 6,544.2% in the 4th quarter. US Bancorp DE now owns 98,932 shares of the company's stock worth $1,113,000 after acquiring an additional 97,443 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Alignment Healthcare by 1.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 847,974 shares of the company's stock worth $9,540,000 after acquiring an additional 8,279 shares during the last quarter. Aigen Investment Management LP bought a new stake in Alignment Healthcare in the 4th quarter worth $129,000. Finally, Raymond James Financial Inc. bought a new stake in Alignment Healthcare in the 4th quarter worth $1,769,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

Alignment Healthcare Stock Down 0.1%

NASDAQ:ALHC traded down $0.01 on Friday, reaching $13.37. 1,667,656 shares of the stock traded hands, compared to its average volume of 2,224,509. The company has a market capitalization of $2.65 billion, a price-to-earnings ratio of -27.85 and a beta of 1.16. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 2.95. Alignment Healthcare, Inc. has a 12 month low of $7.92 and a 12 month high of $21.06. The company's fifty day simple moving average is $14.65 and its 200 day simple moving average is $15.23.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. The business had revenue of $926.93 million during the quarter, compared to analyst estimates of $889.83 million. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. Alignment Healthcare's revenue was up 47.5% compared to the same quarter last year. During the same period last year, the business earned ($0.25) EPS. Equities analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Ratings Changes

ALHC has been the topic of a number of recent analyst reports. Stifel Nicolaus raised their price target on shares of Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a report on Tuesday, April 8th. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. UBS Group raised their price target on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Finally, Robert W. Baird raised their price target on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Alignment Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $17.17.

Insider Transactions at Alignment Healthcare

In other news, CEO John E. Kao sold 180,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, July 10th. The shares were sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the sale, the chief executive officer directly owned 1,553,100 shares in the company, valued at $20,827,071. The trade was a 10.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Andreas P. Wagner sold 19,399 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, June 11th. The stock was sold at an average price of $15.26, for a total transaction of $296,028.74. Following the completion of the sale, the insider owned 204,075 shares of the company's stock, valued at $3,114,184.50. This represents a 8.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,975,262 shares of company stock valued at $275,394,296. Company insiders own 7.00% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.